Johnson & Johnson 2Q Revenues: $18.8 billion (+2%) 2Q Earnings: $3.8 billion (-4%) YTD Revenues: $36.6 billion (+2%) YTD Earnings: $8.2 billion (-2%) Comments: Worldwide Pharmaceutical sales were flat at $8.6 billion in the quarter. Domestic sales were down 3%; international sales increased 3%, which reflected an operational increase of 6% and a negative currency impact of 3%. Remicade sales were down 14% to $1.5 billion. Zytiga sales were down 7% to $558 million. INVOKANA sales were do...